Abstract
Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Current Drug Metabolism
Title:An Overview on the Pharmacokinetics of Quantum Dots
Volume: 14 Issue: 8
Author(s): Xianwei Meng, Li Qiang and Jianfei Wei
Affiliation:
Keywords: Quantum dots, pharmacokinetics, nanoparticles, preparation, quantification.
Abstract: Recent developments in nanotechnology have paved the way for using quantum dots (QDs) in nanodiagnostics and nanotherapeutics. Careful design and preparation of QDs are guided by these application-specific requirements. QDs will probably be one of the first nanomaterial to reach clinical applications, however many challenges in this field have yet to be overcome. In this article, we present an extensive review of the pharmacokinetic properties of QDs. The representative studies responsible for observing quantitative determination of QDs biodistribution in vivo are presented. The effects of size, surface chemistry, and target moiety on their pharmacokinetics are discussed. Finally, future directions for improving the pharmacokinetics of QDs and perspectives in the field are discussed. The understanding of its absorption, distribution, metabolism, and excretion from the body will provide important guidelines for the successful clinical use of QDs.
Export Options
About this article
Cite this article as:
Meng Xianwei, Qiang Li and Wei Jianfei, An Overview on the Pharmacokinetics of Quantum Dots, Current Drug Metabolism 2013; 14 (8) . https://dx.doi.org/10.2174/138920021131400103
DOI https://dx.doi.org/10.2174/138920021131400103 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
Call for Papers in Thematic Issues
Impact of brain tissue binding and plasma protein binding of drugs in DMPK
The impression of brain tissue binding (BTB) or plasma protein binding (PPB) in Drug Metabolism and Pharmacokinetics is critical to understanding the distribution, efficacy, and potential toxicity of drugs that target the central nervous system (CNS). BTB and high PPB influence the distribution of drugs in the body and their ...read more
Interaction between drugs and endocrine diseases
The introduction of highly active antiretroviral therapy accelerated studies and our understanding on the interaction between pharmacological therapies and endocrine diseases. Drugs can precipitate endocrine via different mechanisms, including direct alteration of hormone production and secretion, dysregulation of hormonal axis, effects on hormonal transport, receptor-binding, and cellular signalling. Common drug-induced ...read more
Metabolism-Mediated Xenobiotic Toxicity
Considering the potent modulation of biotransformation enzyme expression and activities by various therapeutic drugs and environmental chemicals, and the commonly combined exposure of humans to both drugs and the ever increasing environmental pollutants simultaneously, knowledge about the combined toxic effects by modulating biotransformation enzymes, such as P450s, UDP- glucuronosyltransferases, and ...read more
Safety evaluation of vaccine combination
Vaccine combination safety evaluation is a critical field within immunology and public health that focuses on assessing the safety and efficacy of combining different vaccines to maximize protection against various diseases while minimizing potential adverse effects. This process is significant because it ensures that vaccines can be administered together without ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment
Current Drug Metabolism An Antileukemic Glutaminase Free L-Asparaginase from Bacillus brevis
Current Biotechnology RNA Interference as A Gene-Specific Approach for Molecular Medicine
Current Medicinal Chemistry Perspectives on Medicinal Properties of Benzoquinone Compounds
Mini-Reviews in Medicinal Chemistry IL-10 Producing Regulatory B Cells in Mice and Humans: State of the Art
Current Molecular Medicine Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology PTD/CPP Peptide-Mediated Delivery of siRNAs
Current Pharmaceutical Design Going 3D – Cell Culture Approaches for Stem Cell Research and Therapy
Current Tissue Engineering (Discontinued) Benzimidazole: A Multifacted Nucelus for Anticancer Agents
Current Organic Chemistry “Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems
Drug Delivery Letters Apoptosis and Autophagy Induction As Mechanism of Cancer Prevention by Naturally Occurring Dietary Agents
Current Drug Targets Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Current Cancer Drug Targets Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase
Recent Patents on Anti-Cancer Drug Discovery The Family is Growing: Old and New Members of the Family of Site- Specific Recombinases and Their Application to Genome Engineering
Current Pharmacogenomics Disodium Phosphate of Novel Pyrazole-Linked Norcantharidin Analogs:Design, Synthesis and their Anticancer Evaluation
Letters in Drug Design & Discovery Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Physiology, Pharmacology and Pathophysiology of the pH Regulatory Transport Proteins NHE1 and NBCn1: Similarities, Differences, and Implications for Cancer Therapy
Current Pharmaceutical Design The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology